NIOX vs. SN, MXCT, EKF, CREO, IUG, NCYT, IHC, POLX, AVO, and MHC
Should you be buying NIOX Group stock or one of its competitors? The main competitors of NIOX Group include Smith & Nephew (SN), MaxCyte (MXCT), EKF Diagnostics (EKF), Creo Medical Group (CREO), Intelligent Ultrasound Group (IUG), Novacyt (NCYT), Inspiration Healthcare Group (IHC), Polarean Imaging (POLX), Advanced Oncotherapy (AVO), and MyHealthChecked (MHC). These companies are all part of the "medical devices" industry.
NIOX Group vs.
Smith & Nephew (LON:SN) and NIOX Group (LON:NIOX) are both large-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, valuation, media sentiment, dividends, analyst recommendations, community ranking, institutional ownership and profitability.
Smith & Nephew presently has a consensus target price of GBX 4,607.50, indicating a potential upside of 345.82%. Given Smith & Nephew's stronger consensus rating and higher probable upside, equities research analysts clearly believe Smith & Nephew is more favorable than NIOX Group.
NIOX Group has a net margin of 28.21% compared to Smith & Nephew's net margin of 5.41%. NIOX Group's return on equity of 13.29% beat Smith & Nephew's return on equity.
In the previous week, Smith & Nephew and Smith & Nephew both had 1 articles in the media. Smith & Nephew's average media sentiment score of 0.00 equaled NIOX Group'saverage media sentiment score.
NIOX Group has lower revenue, but higher earnings than Smith & Nephew. Smith & Nephew is trading at a lower price-to-earnings ratio than NIOX Group, indicating that it is currently the more affordable of the two stocks.
Smith & Nephew pays an annual dividend of GBX 29 per share and has a dividend yield of 2.8%. NIOX Group pays an annual dividend of GBX 1 per share and has a dividend yield of 1.6%. Smith & Nephew pays out 104.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. NIOX Group pays out 4,126.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Smith & Nephew is clearly the better dividend stock, given its higher yield and lower payout ratio.
62.2% of Smith & Nephew shares are held by institutional investors. Comparatively, 35.2% of NIOX Group shares are held by institutional investors. 0.2% of Smith & Nephew shares are held by company insiders. Comparatively, 46.7% of NIOX Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Smith & Nephew has a beta of 0.62, suggesting that its stock price is 38% less volatile than the S&P 500. Comparatively, NIOX Group has a beta of 0.92, suggesting that its stock price is 8% less volatile than the S&P 500.
Smith & Nephew received 559 more outperform votes than NIOX Group when rated by MarketBeat users. However, 100.00% of users gave NIOX Group an outperform vote while only 62.02% of users gave Smith & Nephew an outperform vote.
Summary
Smith & Nephew beats NIOX Group on 10 of the 18 factors compared between the two stocks.
Get NIOX Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for NIOX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
NIOX Group Competitors List
Related Companies and Tools
This page (LON:NIOX) was last updated on 2/22/2025 by MarketBeat.com Staff